Forensic DNA Quantification Using Real-Time PCR: Human DNA, Degradation Index and Inhibition

Learn how forensic DNA quantification by real-time PCR measures human and male DNA, detects degradation and inhibition, and guides STR, Y-STR and MPS workflows.

9 Min Read
The Degradation Index (DI) provides a quantitative value for DNA quality, helping forensic scientists choose the optimal amount of template for PCR to maximize STR and Y-STR allele recovery.

Forensic DNA quantification using real-time PCR (qPCR) estimates amplifiable human nuclear DNA, detects Y-chromosome targets, and provides indicators of DNA degradation and PCR inhibition. These measurements guide decisions before autosomal STR, Y-STR or massively parallel sequencing (MPS) analysis. Importantly, qPCR measures particular amplifiable targets, not every DNA molecule present in an extract.

How real-time PCR measures forensic DNA

Unlike end-point PCR, qPCR monitors fluorescence during amplification. Sequence-specific primers and fluorescent probes detect selected genomic targets. The quantification cycle (Cq, also termed Ct) is the cycle at which fluorescence crosses a defined threshold. Higher starting target concentrations generally produce earlier Cq values, but Cq alone is not a DNA concentration.

Forensic assays usually estimate concentration from a standard curve prepared using DNA standards with assigned concentrations. Cq is plotted against logarithmic concentration; unknowns are interpolated within the validated quantitative range. Laboratories assess standard-curve slope, amplification efficiency, linearity, controls and preparation accuracy. A high R² alone does not establish an unbiased calibration.

The limit of detection differs from the limit of quantification: a target may be detected even when its amount cannot be estimated reliably. At low template levels, stochastic sampling makes the aliquot used for qPCR an imperfect representation of the aliquot subsequently amplified for STR typing. Independent reference materials, including NIST SRM 2372a, can support evaluation of quantification standards.

Human autosomal and male-specific DNA targets

Autosomal human targets

Human autosomal targets estimate nuclear DNA potentially available for autosomal STR amplification. Modern systems may use multicopy targets to improve sensitivity. The reported concentration reflects the assay’s particular amplifiable sequences; severely fragmented molecules lacking an intact target, and mitochondrial DNA without a separate mtDNA assay, are not fully represented.

Y-chromosome targets

Male-specific qPCR targets are useful in evidence containing abundant female DNA and comparatively little Y-target DNA, including some sexual-assault samples. A high autosomal estimate alongside a low Y-target estimate may justify considering differential-extraction fractions or validated Y-STR workflows. However, an autosomal:Y concentration ratio is not an exact male:female cell ratio and does not establish contributor number. Detecting a Y target is not a comprehensive determination of biological sex; failure to detect it does not exclude a low-level male component.

Degradation index: what short and long targets reveal

Fragmentation generally reduces recovery of longer DNA targets before shorter ones. Forensic assays compare short- and longer-amplicon target measurements to generate a degradation index (DI) or related ratio. A relatively high short-target concentration with a much lower long-target concentration supports degradation, especially when internal control behaviour is normal.

There is no universal DI cutoff. Quantifiler Trio, PowerQuant and other systems differ in target loci, amplicon sizes, copy numbers and calculation conventions. Numerical DI thresholds must be interpreted according to the particular kit and laboratory validation; values should not be directly compared across platforms. DI is an indirect integrity indicator, not a fragment-size distribution measurement or guarantee of success at individual STR loci.

PCR inhibition and the internal PCR control

Inhibitors interfere with amplification rather than simply reducing DNA fragment length. Potential sources include haem-associated compounds, humic substances, melanin, calcium-rich material, textile dyes and residual extraction chemicals. Many qPCR kits incorporate an internal PCR control (IPC) at a consistent template amount. A delayed or absent IPC signal relative to validated expectations suggests inhibition.

DI and IPC must be interpreted together. Inhibition can affect different amplicons unequally and can artificially elevate a degradation ratio. Degradation and inhibition can coexist. Conversely, a normal IPC does not prove that all human targets or downstream STR reactions are completely free from inhibitory effects.

Interpreting common forensic qPCR patterns

qPCR findingPossible interpretationValidated next step
Human targets quantifiable; low assay-specific DI; IPC normalRelatively intact, amplifiable DNANormalise to validated STR input
Short target present; long target markedly reduced; IPC normalDegradation more likelyConsider shorter targets or suitable validated MPS strategy
Human signal reduced; IPC delayedInhibition suspectedEvaluate dilution, cleanup or re-extraction
High DI and abnormal IPCDegradation and inhibition may coexistInvestigate both; cleanup cannot restore fragmented DNA
High autosomal estimate; low Y-target estimatePossible female-rich mixtureAssess Y-STR or mixture-specific workflow
Very low signal near assay limitsGreater quantitative and sampling uncertaintyApply low-template validation criteria

From qPCR results to STR, Y-STR and MPS

Quantification informs template input rather than dictating a universal input mass. Too much DNA can produce over-amplification effects; too little increases stochastic imbalance and dropout. The correct target depends on the STR kit, reaction conditions and laboratory validation. A concentrated extract may require dilution. Dilution can also reduce inhibitors, but simultaneously reduces template molecules; low-level samples may instead benefit from validated cleanup or re-extraction where material permits.

For Y-STR analysis, the Y-target estimate can be more informative than total autosomal DNA when the relevant component is minor. It still cannot predict the number of male contributors or guarantee a complete haplotype. For MPS, qPCR informs input, but library preparation may also depend on fragment size, double-stranded integrity and target accessibility.

Four casework examples

  1. Clean blood reference: Quantifiable autosomal DNA, normal IPC and low assay-specific DI support routine normalisation to the validated STR input.
  2. Aged skeletal material: Short target measurable, long target depleted and normal IPC support prioritising a degradation-tolerant, validated typing approach.
  3. Bloodstained denim: Low human signal with delayed IPC suggests possible substrate-associated inhibition. Evaluate dilution or purification rather than automatically increasing extract volume.
  4. Sexual-assault mixture: Abundant autosomal DNA with a small Y-target estimate may support male-targeted processing or Y-STR testing, without implying an exact contributor ratio.

Validation, controls and quality assurance

Forensic laboratories must internally validate analytical procedures for their intended applications. Relevant qPCR studies address sensitivity, quantitative range, precision, specificity, calibration, degradation, inhibition, mixtures and representative evidence matrices. Run acceptance should consider standards, efficiency, positive and negative controls, reagent blanks and IPC performance. Small contamination signals deserve particular scrutiny in low-template casework.

The FBI Quality Assurance Standards effective 1 July 2025, SWGDAM validation guidance and ANSI/ASB Standard 116 provide relevant quality and competency context. Quantification results should not be overinterpreted as proof of contributor identity, exact cellular mixture proportions or absence of inhibition.

Frequently asked questions

What does forensic qPCR actually measure?

It estimates DNA containing the assay’s amplifiable human target sequences, rather than all nucleic acid in an extract.

Are Cq and Ct interchangeable?

They generally refer to a threshold-crossing cycle, but interpretation depends on the assay’s calibration and efficiency.

Can degradation index values be compared between kits?

Not directly. Target design and calculations differ; interpret each result using assay-specific validation.

Can a high degradation index reflect inhibition?

Yes. Inhibitors may disproportionately affect longer targets; examine IPC and other run information.

Does dilution repair degraded DNA?

No. It may reduce inhibitor concentration but cannot restore fragmented molecules.

For the preceding processing stage, read Forensic DNA Extraction Methods and DNA Extraction Validation and Quality Control. For purification chemistry, see Magnetic Bead-Based DNA Extraction and Silica-Based DNA Extraction.

References and further reading

Share This Article
Follow:
Forensic Analyst by Profession. With Simplyforensic.com striving to provide a one-stop-all-in-one platform with accessible, reliable, and media-rich content related to forensic science. Education background in B.Sc.Biotechnology and Master of Science in forensic science.
Leave a Comment